Efficacy of reduced-intensity chemotherapy with oxaliplatin and capecitabine on quality of Life and cancer control among older and frail patients with advanced gastroesophageal cancer: The GO2 phase 3 randomized clinical trial - Hall, PS; Swinson, D; Cairns, DA (JAMA Oncol, 2021)
et al.